House lawmakers bash Trump's Medicare drug pricing efforts

Modern Healthcare: U.S. House of Representatives lawmakers on Tuesday criticized the Trump administration's efforts to introduce formulary management tools such as step therapy into more parts of Medicare.

Republicans and Democrats on the House Energy & Commerce Committee's health subcommittee alleged that the Trump administration's efforts threaten patient access to needed drugs. Step therapy requires a patient to try a cheaper drug before a more expensive drug and prior authorization requires insurance to approve a prescription before it's issued.

Read article